Synthetic peptide agonist analog of LH-RH. Triptoreline is a potent agonist of LH-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Antineoplastic (hormonal). Used in the treatment of endometriosis and infertility.
Mode of Action:
Sanders, L., et al.: Eur. J. Drug Metab. Pharmacokinet., 15, 95 (1990)Chiba, M., et al.: Biomaterials, 18, 893 (1997)Blanco, D., et al.: Eur. J. Pharm. Biopharm., 45, 285 (1998)Sinha, V., et al.: J. Control. Rel., 90, 261 (2003)
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
API’s From Quality Manufacturers:
Cost effective materials based on specific requirements
Small quantities for initial research and larger development quantities towards product commercialization
Technical packages, letters of access to filed DMFs